Literature DB >> 19271207

[Thrombolysis of the middle cerebral artery].

C Brekenfeld1, J Gralla, H-P Mattle, M El-Koussy, G Schroth.   

Abstract

Intravenous thrombolysis (IVT) is the evidence-based treatment of acute ischemic stroke in the first 3 h after symptom onset (IVT 3-4.5 h: off-label use with informed consent of the patient). However, intra-arterial thrombolysis (IAT) results in higher recanalization rates of the middle cerebral artery compared to IVT. Therefore it seems reasonable to apply IAT in addition or instead of IVT up to 6 h after symptom onset.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19271207     DOI： 10.1007/s00117-008-1773-z

Source DB:  PubMed          Journal:  Radiologe        ISSN： 0033-832X            Impact factor:   0.635


  30 in total

1.  Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease.

Authors:  H Zeumer; W Hacke; E B Ringelstein
Journal:  AJNR Am J Neuroradiol       Date:  1983 May-Jun       Impact factor: 3.825

2.  Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study.

Authors:  G J del Zoppo; A Ferbert; S Otis; H Brückmann; W Hacke; J Zyroff; L A Harker; H Zeumer
Journal:  Stroke       Date:  1988-03       Impact factor: 7.914

3.  Local intraarterial fibrinolysis in the carotid territory.

Authors:  J Theron; P Courtheoux; A Casasco; F Alachkar; F Notari; F Ganem; D Maiza
Journal:  AJNR Am J Neuroradiol       Date:  1989 Jul-Aug       Impact factor: 3.825

4.  Symptomatic intracranial haemorrhage after intra-arterial thrombolysis in acute ischaemic stroke: assessment of 294 patients treated with urokinase.

Authors:  C Brekenfeld; L Remonda; K Nedeltchev; M Arnold; H P Mattle; U Fischer; L Kappeler; G Schroth
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03       Impact factor: 10.154

5.  Internal carotid artery stent implantation in 25 patients with acute stroke: preliminary results.

Authors:  Krassen Nedeltchev; Caspar Brekenfeld; Luca Remonda; Christoph Ozdoba; Dai-Do Do; Marcel Arnold; Heinrich P Mattle; Gerhard Schroth
Journal:  Radiology       Date:  2005-10-19       Impact factor: 11.105

6.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

7.  Middle cerebral artery occlusion: correlation of computed tomography and angiography with clinical outcome.

Authors:  I Saito; H Segawa; Y Shiokawa; M Taniguchi; K Tsutsumi
Journal:  Stroke       Date:  1987 Sep-Oct       Impact factor: 7.914

8.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

9.  Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study.

Authors:  T Neumann-Haefelin; R du Mesnil de Rochemont; J B Fiebach; A Gass; C Nolte; T Kucinski; J Rother; M Siebler; O C Singer; K Szabo; A Villringer; P D Schellinger
Journal:  Stroke       Date:  2003-12-11       Impact factor: 7.914

10.  Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign.

Authors:  Heinrich P Mattle; Marcel Arnold; Dimitrios Georgiadis; Christian Baumann; Krassen Nedeltchev; David Benninger; Luca Remonda; Christian von Büdingen; Anca Diana; Athina Pangalu; Gerhard Schroth; Ralf W Baumgartner
Journal:  Stroke       Date:  2007-12-20       Impact factor: 7.914
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.